Literature DB >> 144704

Use of transferrin-iron enterobactin complexes as the source of iron by serum-exposed bacteria.

J T Kvach, T I Wiles, M W Mellencamp, I Kochan.   

Abstract

Two smooth and six rough strains of Salmonella typhimurium with progressively smaller amounts of sugar and protein in their outer membrane were tested for degree of virulence in normal and iron-injected mice and for ability to acquire iron in mammalian sera. The rate of mortality showed that bacterial virulence for mice was lowered with progressive decrease of outer-membrane sugar and protein. Iron injections increased the rate of mortality in mice infected either with smooth strains or with superficially rough strains but were without effect in mice infected with deep rough strains. In in vitro experiments, iron promoted with equal effectiveness the growth of all serum-exposed bacterial strains, whereas enterobactin (E) was much more effective in promoting the growth of smooth and superficial rough than in promoting that of deep rough strains. Various experiments showed that deep rough strains cannot grow in E-supplemented serum because they are not able to use the transferrin-iron-E complexes that E forms with transferrin-iron. This failure to use transferrin-iron-E complexes by deep rough strains was found to be due to the inability of these strains to absorb iron containing complexes to their outer membrane. Adsorption studies with chemically treated bacteria showed that the receptor of transferrin-iron-E or E-iron complexes is a protein of the outer membrane of bacterial cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 144704      PMCID: PMC421252          DOI: 10.1128/iai.18.2.439-445.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Physical, chemical, and immunological properties of lipopolysaccharide released from Escherichia coli by ethylenediaminetetraacetate.

Authors:  L Leive; V K Shovlin; S E Mergenhagen
Journal:  J Biol Chem       Date:  1968-12-25       Impact factor: 5.157

2.  Characterization of the virulence and antigenic structure of Salmonella typhimurium strains with lipopolysaccharide core defects.

Authors:  M B Lyman; J P Steward; R J Roantree
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

3.  Iron transport in Salmonella typhimurium LT-2: prevention, by ferrichrome, of adsorption of bacteriophages ES18 and ES18.h1 to a common cell envelope receptor.

Authors:  M Luckey; J B Neilands
Journal:  J Bacteriol       Date:  1976-08       Impact factor: 3.490

4.  Role of mycobactin in the growth and virulence of tubercle bacilli.

Authors:  C A Golden; I Kochan; D R Spriggs
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

5.  The effect of passage and iron on the virulence of Pseudomonas aeruginosa.

Authors:  C M Forsberg; J J Bullen
Journal:  J Clin Pathol       Date:  1972-01       Impact factor: 3.411

6.  Pathogenesis and immunology of experimental gonococcal infection: role of iron in virulence.

Authors:  S M Payne; R A Finkelstein
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

7.  Colicin B: mode of action and inhibition by enterochelin.

Authors:  S K Guterman
Journal:  J Bacteriol       Date:  1973-06       Impact factor: 3.490

8.  Virulence-associated acquisition of iron in mammalian serum by Escherichia coli.

Authors:  I Kochan; J T Kvach; T I Wiles
Journal:  J Infect Dis       Date:  1977-04       Impact factor: 5.226

9.  Protein composition of the outer membrane of Salmonella typhimurium: effect of lipopolysaccharide mutations.

Authors:  G F Ames; E N Spudich; H Nikaido
Journal:  J Bacteriol       Date:  1974-02       Impact factor: 3.490

10.  Siderophore protection against colicins M, B, V, and Ia in Escherichia coli.

Authors:  R Wayne; K Frick; J B Neilands
Journal:  J Bacteriol       Date:  1976-04       Impact factor: 3.490

View more
  18 in total

Review 1.  Interdependence between iron acquisition and biofilm formation in Pseudomonas aeruginosa.

Authors:  Donghoon Kang; Natalia V Kirienko
Journal:  J Microbiol       Date:  2018-06-14       Impact factor: 3.422

2.  The growth-promoting effect of bacterial iron for serum-exposed bacteria.

Authors:  M W Mellencamp; M A McCabe; I Kochan
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

3.  Effects of iron and culture filtrates on killing of Neisseria gonorrhoeae by normal human serum.

Authors:  P Norrod; R P Williams
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

4.  Innate resistance of mice to Salmonella typhi infection.

Authors:  A D O'Brien
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

5.  Effect of iron on antibacterial immunity in vaccinated mice.

Authors:  I Kochan; S K Wagner; J Wasynczuk
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

6.  Effects of injected iron and siderophores on infections in normal and immune mice.

Authors:  I Kochan; J Wasynczuk; M A McCabe
Journal:  Infect Immun       Date:  1978-11       Impact factor: 3.441

7.  Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds.

Authors:  P A Mickelsen; P F Sparling
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

8.  The ability of Salmonella typhimurium to produce the siderophore enterobactin is not a virulence factor in mouse typhoid.

Authors:  W H Benjamin; C L Turnbough; B S Posey; D E Briles
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Role of antibody and enterobactin in controlling growth of Escherichia coli in human milk and acquisition of lactoferrin- and transferrin-bound iron by Escherichia coli.

Authors:  J H Brock; M G Pickering; M C McDowall; A G Deacon
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

10.  Iron-controlled infection with Neisseria meningitidis in mice.

Authors:  B E Holbein
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.